Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Aug 2020
ReviewClinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.
Primary care practitioners (PCPs) and diabetologists are at the frontline of potentially encountering patients with NASH. Identification of those at high risk for adverse outcomes is important. ⋯ Due to the growing burden of NAFLD and NASH, PCPs and diabetologists are faced with increased patient encounters in their clinical practices necessitating referral decisions. To assist in identifying high-risk NASH patients requiring specialty care, we provide a simple and easy to use algorithm.